WAAG
ANIX icon

Wealth Alliance Advisory Group’s Anixa Biosciences ANIX Stock Holding History

Wealth Alliance Advisory Group’s Portfolio ANIX Stock Details ANIX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-16,413
Closed -$78K – 166
2021
Q3 		$78K Buy
+16,413
New +$74K 0.04% 146
2021
Q2 		– Sell
-20,100
Closed -$94K – 152
2021
Q1 		$94K Buy
+20,100
New +$96K 0.05% 151

Other funds holding ANIX

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
RJA
Raymond James & Associates St Petersburg, Florida $164B AUM 33.91% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Wealth Alliance Advisory Group's ANIX Position: Q4 2021 in Review

Wealth Alliance Advisory Group sold out of Anixa Biosciences (ANIX) in Q4 2021, closing a stake of 16,413 shares — an estimated $78K sold.

Wealth Alliance Advisory Group first reported a position in ANIX in Q1 2021 and held it in 2 quarters. The position peaked at $94K in Q1 2021. 42 funds tracked by Wall St. Rank hold ANIX as of Q4 2021.

  • Wealth Alliance Advisory Group reported no remaining Anixa Biosciences position as of Q4 2021 after selling out during the quarter.
  • Wealth Alliance Advisory Group sold 16,413 Anixa Biosciences shares in Q4 2021, an estimated $78K.
  • Wealth Alliance Advisory Group first reported a position in Anixa Biosciences in Q1 2021 and held it in 2 quarters.
  • Wealth Alliance Advisory Group's Anixa Biosciences position peaked at $94K in Q1 2021.
  • 42 funds tracked by Wall St. Rank held Anixa Biosciences as of Q4 2021.

Based on Wealth Alliance Advisory Group's 13F filing for Q4 2021, filed 13 Jan 2022.